Market By Product, Application, And Geography | Forecast 2019-2028
The Asia-Pacific opioid drugs market is expected to make progress at a CAGR of 3.05% in terms of revenue throughout the estimated period 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries studied in this market include:
• China
• Japan
• South Korea
• ASEAN countries
• Australia & New Zealand
• India
• Rest of APAC
China, being a highly populous country, has a huge number of cancer patients. It is estimated that, each year, around 1.8 million patients are found to be affected by cancer, and 1.4 million patients die from this deadly condition. Considering the urban population, cancer is the primary cause of death, among all commonly occurring diseases; whereas, considering the population in the rural areas, it is the second-leading cause of death. Whether it is cancer-associated or non-cancer-associated pain, pain management is a critical issue in the care of patients suffering from both. Opioid drugs have proven extremely beneficial in this scenario, owing to their role in pain management. This is helping the growth of the Chinese opioid drugs market over the forecast period.
As per a report, the consumption of opioid analgesics in Japan is 15.5%, considering the calculated requirement. This is remarkably low, when compared with other nations, such as the US, France, and the UK. However, in recent years, owing to the expansion of opioid indications to include non-cancer chronic pain, the annual consumption of opioid drugs in the country is expected to increase. Owing to this increase in consumption, it is predicted that the inappropriate use of opioids may also rise in the country, thereby resulting in several AE-related deaths. Therefore, to promote appropriate opioid use, training is being imparted to physicians, nurses, and pharmacists. By taking such initiatives, the government hopes there will be more responsible use of opioid drugs in the country, which will help in the growth of the market.
Daiichi Sankyo is a renowned pharmaceutical company, headquartered in Tokyo, Japan. With over 100 years of expertise, it provides a range of opioid analgesics to help patients in pain management. These include, Narusus® Tablets and Narurapid® Tablets, as well as injections like Naruvein® Injection, Oxycodone Injections 50 mg, and Oxycodone Injections 10 mg. The company lays a strong focus on R&D.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1.   ASIA-PACIFIC OPIOID DRUGS MARKET - SUMMARY
2.   INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. TECHNOLOGICAL ADVANCEMENTS TO FIGHT AGAINST OPIOID DRUG CRISIS
2.2.2. DIFFERENT SOURCES OF PROCURING OPIOIDS
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. GROWTH IN MEDICAL CASES & RISING PREVALENCE OF CANCER
2.6.2. INCREASE IN THE USE OF ABUSE-DETERRENT FORMULATIONS TO RESTRICT THE RISE OF OPIOID DEPENDENCE
2.6.3. DEMAND FOR PALLIATIVE THERAPY
2.7. MARKET RESTRAINTS
2.7.1. GOVERNMENT RULES & REGULATIONS
2.7.2. INCREASED NUMBER OF LAWSUITS AGAINST MANUFACTURERS OF OPIOID DRUGS
2.7.3. USAGE OF OPIOIDS FOR NON-MEDICAL PURPOSES
2.8. MARKET OPPORTUNITIES
2.8.1. RISING COMMERCIAL SUCCESS AND MARKET SHARE OF OPIOID DRUGS
2.8.2. GROWTH IN INVESTMENTS IN RESEARCH OF PHARMACEUTICAL USES OF OPIOIDS
2.9. MARKET CHALLENGES
2.9.1. OPIOIDS EPIDEMIC SPREAD
2.9.2. RISING DEATH RATE DUE TO OPIOIDS OVERDOSE
2.10. COVID-19 IMPACT ON THE OPIOID DRUGS MARKET
3.   ASIA-PACIFIC OPIOID DRUGS MARKET OUTLOOK - BY PRODUCT
3.1. BUPRENORPHINE
3.2. FENTANYL
3.3. HYDROCODONE
3.4. MORPHINE
3.5. OXYCODONE
3.6. TRAMADOL
3.7. OTHER PRODUCTS
4.   ASIA-PACIFIC OPIOID DRUGS MARKET OUTLOOK - BY APPLICATION
4.1. PAIN RELIEF
4.1.1. CANCER PAIN
4.1.2. POSTOPERATIVE PAIN MANAGEMENT
4.1.3. LOWER BACK PAIN
4.1.4. ORTHOPEDIC
4.1.5. NEUROPATHIC
4.1.6. FIBROMYALGIA
4.2. ANESTHESIA
4.3. COUGH SUPPRESSION
4.4. DIARRHEA SUPPRESSION
4.5. DE-ADDICTION
5.   ASIA-PACIFIC OPIOID DRUGS MARKET – REGIONAL OUTLOOK
      5.1. CHINA      5.2. JAPAN
      5.3. INDIA
     5.4. SOUTH KOREA
     5.5. ASEAN COUNTRIES
     5.6. AUSTRALIA & NEW ZEALAND
     5.7. REST OF ASIA-PACIFIC
6.   COMPETITIVE LANDSCAPE
6.1. ACURA PHARMACEUTICALS
6.2. BIODELIVERY SCIENCES INTERNATIONAL INC
6.3. CIPHER PHARMACEUTICALS INC
6.4. ALLERGAN (ACQUIRED BY ABBVIE)
6.5. COLLEGIUM PHARMACEUTICAL INC
6.6. DAIICHI SANKYO
6.7. HIKMA PHARMACEUTICALS PLC
6.8. INDIVIOR INC
6.9. JANSSEN PHARMACEUTICALS INC
6.10. JOHNSON JOHNSON
6.11. LANNETT CO INC
6.12. LUPIN LTD
6.13. MYLAN NV
6.14. PFIZER INC
6.15. PURDUE PHARMA LP
6.16. SANOFI-AVENTIS SA
6.17. SUN PHARMACEUTICAL INDUSTRIES LTD
6.18. TEVA PHARMACEUTICAL INDUSTRIES LTD
7.   METHODOLOGY & SCOPE
7.1. RESEARCH SCOPE & DELIVERABLES
7.2. SOURCES OF DATA
7.3. RESEARCH METHODOLOGY
TABLE 1: ASIA-PACIFIC OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: ASIA-PACIFIC OPIOID DRUGS MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC OPIOID DRUGS MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC OPIOID DRUGS MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS INDEX
FIGURE 3: ASIA-PACIFIC OPIOID DRUGS MARKET, BY BUPRENORPHINE, 2019-2028 (IN $ MILLION)
FIGURE 4: ASIA-PACIFIC OPIOID DRUGS MARKET, BY FENTANYL, 2019-2028 (IN $ MILLION)
FIGURE 5: ASIA-PACIFIC OPIOID DRUGS MARKET, BY HYDROCODONE, 2019-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC OPIOID DRUGS MARKET, BY MORPHINE, 2019-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC OPIOID DRUGS MARKET, BY OXYCODONE, 2019-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC OPIOID DRUGS MARKET, BY TRAMADOL, 2019-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC OPIOID DRUGS MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC OPIOID DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC OPIOID DRUGS MARKET, BY CANCER PAIN, 2019-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC OPIOID DRUGS MARKET, BY POSTOPERATIVE PAIN MANAGEMENT, 2019-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC OPIOID DRUGS MARKET, BY LOWER BACK PAIN, 2019-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC OPIOID DRUGS MARKET, BY ORTHOPEDIC, 2019-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC OPIOID DRUGS MARKET, BY NEUROPATHIC, 2019-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC OPIOID DRUGS MARKET, BY FIBROMYALGIA, 2019-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC OPIOID DRUGS MARKET, BY ANESTHESIA, 2019-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC OPIOID DRUGS MARKET, BY COUGH SUPPRESSION, 2019-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC OPIOID DRUGS MARKET, BY DIARRHEA SUPPRESSION, 2019-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC OPIOID DRUGS MARKET, BY DE-ADDICTION, 2019-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC OPIOID DRUGS MARKET; REGIONAL OUTLOOK 2019 & 2028 (IN %)
FIGURE 22: CHINA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 23: JAPAN OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 24: INDIA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 25: SOUTH KOREA OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 26: ASEAN COUNTRIES OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 27: AUSTRALIA & NEW ZEALAND OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)
FIGURE 28: REST OF ASIA-PACIFIC OPIOID DRUGS MARKET, 2019-2028 (IN $ MILLION)